Abstract | STUDY OBJECTIVE: METHODS: Randomized controlled trials were identified using MEDLINE, EMBASE, other computerized databases, hand searching, bibliographies, and contacts with industry and authors. Studies in which dihydroergotamine (alone or in combination with an antiemetic) was compared with placebo or any other common migraine therapy were considered. Relevance, inclusion, and study quality were assessed independently by 2 reviewers. RESULTS: CONCLUSION:
|
Authors | Ian Colman, Michael D Brown, Grant D Innes, Eric Grafstein, Ted E Roberts, Brian H Rowe |
Journal | Annals of emergency medicine
(Ann Emerg Med)
Vol. 45
Issue 4
Pg. 393-401
(Apr 2005)
ISSN: 1097-6760 [Electronic] United States |
PMID | 15795718
(Publication Type: Journal Article, Review, Systematic Review)
|
Chemical References |
- Antiemetics
- Dihydroergotamine
|
Topics |
- Adult
- Antiemetics
(therapeutic use)
- Dihydroergotamine
(administration & dosage, adverse effects, therapeutic use)
- Drug Therapy, Combination
- Humans
- Injections, Intravenous
- Migraine Disorders
(drug therapy)
- Randomized Controlled Trials as Topic
|